A Study on Building a Voice Cohort for the Development of a Non-face-to-face Machine Learning Diagnostic and Monitoring Platform Using Voice Analysis and Various Sensors in Patients With Dysphagia.

Sponsor
Seoul National University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05439447
Collaborator
(none)
200
1
24
8.3

Study Details

Study Description

Brief Summary

Collection of basic data for real-time analysis and monitoring by measuring what changes in voice occur according to the state of dysphagia using voice analysis and various sensors.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Patients scheduled for VFSS testing group

Detailed Description

  • Design : Prospective cohort study

  • Setting : Hospital rehabilitation department

  • Inclusion criteria of the patient group : Patients scheduled for VFSS examination

  • Intervention

  • This study will be conducted after collecting basic information such as age, gender, and disease of patients who met the inclusion criteria among patients scheduled to undergo a video fluoroscopic swallowing test (VFSS test) for the diagnosis of dysphagia, and after obtaining guidance and consent through the study description will do.

  • Before the subject's VFSS test, "Ah for 5 seconds", after clearing the throat, "Ah for 5 seconds", and briefly cut with a slightly high sound, "Ah. oh Ah.", shut lips lightly and read "Ummm~~~~", read a short sentence.

  • While the subject makes the above sound, voice is recorded, video is taken, and integrated sensors such as a microphone (sound detection) sensor and surface electromyography sensor are attached to measure changes in each sensor.

  • After the VFSS test, participants will repeat the above sound and record the same twice. (As before the test, imaging of the patient's swallowing is also performed.)

  • Using voice analysis, various sensor values, and image information, a voice indicator that can predict the amount of suction and residue on the VFSS test is found.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Study on Building a Voice Cohort for the Development of a Non-face-to-face Machine Learning Diagnostic and Monitoring Platform Using Voice Analysis and Various Sensors in Patients With Dysphagia.
Anticipated Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Jun 30, 2023
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Patients scheduled for VFSS examination due to dysphagia.

Diagnostic Test: Patients scheduled for VFSS testing group
Patients scheduled for VFSS testing, patient with voice.

Outcome Measures

Primary Outcome Measures

  1. Voice analysis before and after meals, the results are compared with VFSS to verify significant indicators (residue, aspiration, etc.) by Paired t-test analysis. [Baseline/ Change from baseline when swallowing]

    By comparing the VFSS swallow test result with the analysis value through voice analysis, the accuracy of the case classified as aspiration in the voice test is used as the primary indicator.

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Those who are 19 years of age or older and do not fall under the exclusion criteria

  • Patients scheduled for VFSS test

  • Patients who can record voices such as "Ah.", "Ummm~~~", short sentences

  • Patients who can attach sensor on their throat

  • Those who voluntarily consent to the clinical trial

Exclusion Criteria:
  • Those who do not agree to participate in this study

  • Patients who can not follow Step 1 instructions

  • Patients who can not vocalize or follow to speak

  • Patients who cannot apply the sensor due to skin allergy or hypersensitivity to sensor attachment

  • Other who have comorbidities (e.g., maligant tumors, blood clotting abnormalities, etc.) that are inappropriate for clinical trial participation by the judgment of the researcher 6) Other who are judged by the researcher to be unsuitable for this clinical trial.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine Seongnam-si Gyeonggi-do Korea, Republic of 463-707

Sponsors and Collaborators

  • Seoul National University Hospital

Investigators

  • Study Director: Juseok Ryu, M.D, PhD, Seoul National University Bundang Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ju Seok Ryu, Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT05439447
Other Study ID Numbers:
  • B-2206-761-302
First Posted:
Jun 30, 2022
Last Update Posted:
Jul 6, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2022